MAPK
Les MAPK sont une famille de kinases protéiques impliquées dans une variété de processus cellulaires, y compris la croissance, la prolifération, la différenciation et les réponses au stress. La voie de signalisation MAPK comprend plusieurs niveaux, y compris ERK, JNK et p38 MAPK, chacun jouant des rôles distincts dans la fonction cellulaire. La dérégulation de la signalisation MAPK est liée au cancer, aux maladies inflammatoires et aux troubles métaboliques. Chez CymitQuimica, nous offrons un large éventail d'inhibiteurs et d'activateurs de MAPK pour soutenir vos recherches en biologie cellulaire, transduction de signaux et mécanismes des maladies.
886 produits trouvés pour "MAPK"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
ASP2453
CAS :<p>ASP2453 is a potent, selective and covalent inhibitor of KRAS G12C.</p>Formule :C40H48F3N7O4Degré de pureté :99.71%Couleur et forme :SolidMasse moléculaire :747.85PLX-4720
CAS :<p>PLX-4720 is a potent and selective B-Raf (V600E) inhibitor designed to block the ATP-binding site of oncogenic B-Raf.Cost-effective and quality-assured.</p>Formule :C17H14ClF2N3O3SDegré de pureté :97.78% - 99.83%Couleur et forme :SolidMasse moléculaire :413.83ERK-IN-3
CAS :<p>ERK-IN-3 (ASN007 free base) is a potent and orally active inhibitor of ERK.</p>Formule :C22H25ClFN7O2Degré de pureté :99.55% - 99.76%Couleur et forme :SolidMasse moléculaire :473.93ERK5-IN-2
CAS :<p>ERK5-IN-2 is an orally active, sub-micromolar, selective ERK5 inhibitor with IC50s of 0.82 μM, 3 μM for ERK5 and ERK5 MEF2D, respectively.</p>Formule :C17H11BrFN3O2Degré de pureté :99.01%Couleur et forme :SolidMasse moléculaire :388.19SKF-86002
CAS :<p>SKF-86002 is an effective inhibitor of p38 MAP kinase (IC50: 0.5-1 uM); inhibits LPS-induced IL-1 and TNF-α production in human monocytes (IC50: 1 μM).</p>Formule :C16H12FN3SDegré de pureté :98% - 99.85%Couleur et forme :SolidMasse moléculaire :297.35BAY-293
CAS :<p>BAY-293 is a potent, cell-active SOS1 inhibitor that disrupts the KRAS-SOS1 interaction (IC50: 21 nM).</p>Formule :C25H28N4O2SDegré de pureté :97.16%Couleur et forme :SolidMasse moléculaire :448.58(S)-AMG-510
CAS :<p>(S)-AMG-510 is the S-type compound of AMG-510 (Sotorasib), which effectively and selectively inhibits KRASG12C.Cost-effective and quality-assured.</p>Formule :C30H30F2N6O3Degré de pureté :99.05% - 99.76%Couleur et forme :SolidMasse moléculaire :560.594BI-D1870
CAS :<p>BI-D1870 is a highly specific, blood-brain-permeable, and ATP-competitive inhibitor of the N-terminal AGC kinase domain of RSK.Cost-effective and quality-assured.</p>Formule :C19H23F2N5O2Degré de pureté :98.51% - 99.43%Couleur et forme :SolidMasse moléculaire :391.42Locostatin
CAS :<p>Locostatin is a potent and cell permeable inhibitor of Raf kinase inhibitor protein (RKIP)/Raf1 kinase interaction and an inhibitor of cell migration.</p>Formule :C14H15NO3Degré de pureté :97.13%Couleur et forme :SolidMasse moléculaire :245.27SB 239063
CAS :<p>SB 239063 (SB239063) is a potent and selective p38 MAPKα/β inhibitor with IC50 of 44 nM, showing no activity against the γ- and δ-kinase isoforms.</p>Formule :C20H21FN4O2Degré de pureté :99.42% - 99.81%Couleur et forme :SolidMasse moléculaire :368.4Pimasertib
CAS :<p>Pimasertib (AS703026) is an orally bioavailable small-molecule inhibitor of MEK1 and MEK2 (MEK1/2) with potential antineoplastic activity.</p>Formule :C15H15FIN3O3Degré de pureté :98.25% - 99.57%Couleur et forme :SolidMasse moléculaire :431.2Skepinone-L
CAS :<p>Skepinone-L (CBS3830) is a selective p38 mitogen-activated protein kinase inhibitor.</p>Formule :C24H21F2NO4Degré de pureté :99.56% - >99.99%Couleur et forme :SolidMasse moléculaire :425.42LM22B-10
CAS :<p>LM22B-10 is an activator of TrkB/TrkC neurotrophin receptor and can induce TrkB, TrkC, ERK and AKT activation in vitro and in vivo.</p>Formule :C27H33ClN2O4Degré de pureté :98.18%Couleur et forme :SolidMasse moléculaire :485.01Tomivosertib
CAS :<p>Tomivosertib (eFT508) is a potent, highly selective MNK1 and MNK2 inhibitor with IC50 value of 1-2 nM.</p>Formule :C17H20N6O2Degré de pureté :97.34% - 99.72%Couleur et forme :SolidMasse moléculaire :340.38APS6-45
CAS :<p>APS6-45 inhibits RAS/MAPK signaling and exhibits anti-tumor activity.</p>Formule :C23H16F8N4O3Degré de pureté :99.39%Couleur et forme :SolidMasse moléculaire :548.39GW 284543 hydrochloride
CAS :<p>GW 284543 hydrochloride is a selective inhibitor of MEK5 .</p>Formule :C23H21ClN2O3Degré de pureté :99.73%Couleur et forme :SolidMasse moléculaire :408.87CC-401 Hydrochloride
CAS :<p>CC-401 Hydrochloride (CC401 HCl) is a second generation ATP-competitive anthrapyrazolone c-Jun N terminal kinase (JNK) inhibitor with antineoplastic activity.</p>Formule :C22H25ClN6ODegré de pureté :99.71% - ≥95%Couleur et forme :SolidMasse moléculaire :424.93PF-4708671
CAS :<p>PF-4708671 is a cell-permeable inhibitor of p70 ribosomal S6 kinase (S6K1 isoform) .In cell-free assays, PF-4708671 is potent for S6K1(Ki50=20 nM, IC50=160 nM).</p>Formule :C19H21F3N6Degré de pureté :99.48% - 99.67%Couleur et forme :SolidMasse moléculaire :390.41BI-78D3
CAS :<p>BI-78D3, a competitive JNK inhibitor. IC50 of BI-78D3 is 280 nM that displays > 100 fold selectivity over p38α, and have no activity at mTOR and PI-3K.</p>Formule :C13H9N5O5S2Degré de pureté :97.89% - >99.99%Couleur et forme :SolidMasse moléculaire :379.37PLX8394
CAS :<p>Plixorafenib (PLX8394) is an orally active inhibitor of the serine/threonine protein kinase B-Raf (BRAF) protein.Cost-effective and quality-assured.</p>Formule :C25H21F3N6O3SDegré de pureté :98.75% - >99.99%Couleur et forme :SolidMasse moléculaire :542.53Sotorasib
CAS :<p>Sotorasib (AMG-510) is an orally active and selective covalent inhibitor of KRAS G12C.</p>Formule :C30H30F2N6O3Degré de pureté :98% - 99.95%Couleur et forme :SolidMasse moléculaire :560.594S6K-18
CAS :<p>S6K-18, a highly selective S6K1 inhibitor, inhibits S6K1 with IC50 of 52nM.</p>Formule :C17H18N4O3SDegré de pureté :98.99%Couleur et forme :SolidMasse moléculaire :358.41Binimetinib
CAS :<p>Binimetinib (ARRY-162) is a MEK1/2 inhibitor (IC50=12 nM) with selective and oral activity. Binimetinib has antitumor activity. Cost-effective and quality-assured.</p>Formule :C17H15BrF2N4O3Degré de pureté :98.03% - >99.99%Couleur et forme :SolidMasse moléculaire :441.23SGX-523
CAS :<p>SGX-523 is a selective Met inhibitor (IC50: 4 nM), no inhibitory to Abl, BRAFV599E, p38α, and c-Raf.</p>Formule :C18H13N7SDegré de pureté :99% - >99.99%Couleur et forme :SolidMasse moléculaire :359.41SB 242235
CAS :<p>SB 242235 is a potent and selective p38 MAP kinase inhibitor that may be an effective therapy for cytokine-mediated diseases.</p>Formule :C19H20FN5ODegré de pureté :99.13% - 99.68%Couleur et forme :SolidMasse moléculaire :353.39TA-01
CAS :<p>TA-01 is a potent CK1 and p38 MAPK inhibitor, with IC50s of 6.4 nM, 6.8 nM, 6.7 nM for CK1ε, CK1δ and p38 MAPK, respectively.</p>Formule :C20H12F3N3Degré de pureté :99.55% - 99.94%Couleur et forme :SolidMasse moléculaire :351.32Tizoxanide
CAS :<p>Tizoxanide (Desacetyl-nitazoxanide) is a metabolite of lamivudine.</p>Formule :C10H7N3O4SDegré de pureté :98.89% - 99.28%Couleur et forme :SolidMasse moléculaire :265.25Losmapimod
CAS :<p>Losmapimod (GSK-AHAB) (GW856553X; SB856553; GSK-AHAB) is a specific, potent, and orally active p38 MAPK inhibitor (pKi: 8.1/7.6 for p38α/β).</p>Formule :C22H26FN3O2Degré de pureté :98.35% - 99.89%Couleur et forme :SolidMasse moléculaire :383.46Dabrafenib
CAS :<p>Dabrafenib (GSK2118436A) is a Raf inhibitor that inhibits C-Raf and B-RafV600E (IC50=5/0.6 nM) and is ATP-competitive.</p>Formule :C23H20F3N5O2S2Degré de pureté :99.62% - >99.99%Couleur et forme :SolidMasse moléculaire :519.56BIX02189
CAS :<p>BIX02189 is a potent and selective inhibitor of MEK5 and ERK5(IC50 : 1.5 nM and 59 nM).</p>Formule :C27H28N4O2Degré de pureté :97.84%Couleur et forme :SolidMasse moléculaire :440.54Theaflavin 3,3′-digallate
CAS :<p>Theaflavin 3,3'-digallate, a major polyphenol found in black tea, is an inducer of oxidative stress which has anti-inflammatory and cancer</p>Formule :C43H32O20Degré de pureté :98.71% - 99.86%Couleur et forme :SolidMasse moléculaire :868.7Raf inhibitor 2
CAS :<p>Raf inhibitor 2 (CID 25014542) is novel inhibitor of Raf kinases.</p>Formule :C15H8Br2ClNO2Degré de pureté :98.53%Couleur et forme :SolidMasse moléculaire :429.49Ro 5126766
CAS :<p>RO5126766 (CH5126766) is a dual RAF/MEK inhibitor with IC50 of 8.2 nM, 19 nM, 56 nM, and 160 nM for BRAF V600E, BRAF, CRAF, and MEK1, respectively. Phase 1.</p>Formule :C21H18FN5O5SDegré de pureté :98.3% - 98.81%Couleur et forme :SolidMasse moléculaire :471.46SCH54292
CAS :<p>SCH-54292 is a GDP exchange inhibitor.</p>Formule :C24H28N2O9SDegré de pureté :95.65%Couleur et forme :SolidMasse moléculaire :520.55BAY885
CAS :<p>BAY885 is a new ERK5 inhibitor.</p>Formule :C25H28F3N7O2Degré de pureté :99.83%Couleur et forme :SolidMasse moléculaire :515.53NG25 trihydrochloride
CAS :<p>NG25 trihydrochloride: kinase inhibitor for MAP4K2, TAK1, Src, LYN, Abl, CSK, FER, p38α; blocks TNF-α signals; impedes IFN secretion; anti-cancer properties.</p>Formule :C29H33Cl3F3N5O2Couleur et forme :SolidMasse moléculaire :646.96SL327
CAS :<p>SL327 is a selective inhibitor for MEK1/2 with IC50 of 0.18 μM/0.22 μM; able to transport through the blood-brain barrier.</p>Formule :C16H12F3N3SDegré de pureté :97.98% - >99.99%Couleur et forme :SolidMasse moléculaire :335.35LY3009120
CAS :<p>LY3009120 (DP-4978) is a potent pan-Raf inhibitor with IC50 of 44 nM, 31-47 nM, and 42 nM for A-raf, B-Raf, and C-Raf in A375 cells, respectively. Phase 1.</p>Formule :C23H29FN6ODegré de pureté :96.96% - ≥95%Couleur et forme :SolidMasse moléculaire :424.51SR-318
CAS :<p>SR-318 inhibits TNF-α (IC50=283 nM), selectively targets p38 MAPK: IC50 of 5nM (p38α), 32nM (p38β), 6.11μM (p38α/β).</p>Formule :C27H33N5O2Degré de pureté :99.74%Couleur et forme :SolidMasse moléculaire :459.58TAO Kinase inhibitor 1
CAS :TAO Kinase inhibitor 1 delays mitosis and induces mitotic cell death.Formule :C25H24N2O2Degré de pureté :99.74%Couleur et forme :SolidMasse moléculaire :384.47A-443654
CAS :<p>A-443654 is a pan-Akt inhibitor. A-443654 has equal potency against Akt1, Akt2, or Akt3 within cells (Ki=160 pM).</p>Formule :C24H23N5ODegré de pureté :98.04% - 99.51%Couleur et forme :SolidMasse moléculaire :397.47JIP-1 (153-163) acetate(438567-88-5 free base)
<p>JNK peptide inhibitor. Mimics JIP-1 residues 153-163. Micromolar affinity, little effect on p38, ERK.</p>Formule :C63H108N20O16Degré de pureté :92.89%Couleur et forme :SolidMasse moléculaire :1401.65TAK-632
CAS :<p>TAK-632 is a potent pan-Raf inhibitor.</p>Formule :C27H18F4N4O3SDegré de pureté :98% - 99.5%Couleur et forme :SolidMasse moléculaire :554.522-(4-methoxyphenyl)-2-oxoethyl 2-hydroxy-5-methylbenzoate
CAS :<p>Pro-neurotropic drug boosts brain acetylcholine synthesis and release, inhibits breakdown.</p>Formule :C17H16O5Degré de pureté :98.68%Couleur et forme :SolidMasse moléculaire :300.31Pluripotin
CAS :<p>Pluripotin (SC1) (SC1), which keep embryonic stem cell (ESC) self-renewal, is a dual inhibitor of extracellular signal-regulated kinase 1 (ERK1, MAPK3) and</p>Formule :C27H25F3N8O2Degré de pureté :98.77% - 98.82%Couleur et forme :SolidMasse moléculaire :550.53SCH772984
CAS :<p>SCH772984 is an ERK inhibitor and is highly selective and ATP-competitive. SCH772984 exhibits antitumor activity. Cost-effective and quality-assured.</p>Formule :C33H33N9O2Degré de pureté :97.565% - 98.75%Couleur et forme :SolidMasse moléculaire :587.67TAK-715
CAS :<p>TAK-715 is a p38 MAPK inhibitor for p38α.</p>Formule :C24H21N3OSDegré de pureté :99.83%Couleur et forme :SolidMasse moléculaire :399.51APS-2-79
CAS :<p>APS-2-79: KSR-dependent MEK inhibitor, blocks ATP biotin at KSR2, IC50 of 120 nM, disrupts Ras-MAPK signaling.</p>Formule :C23H21N3O3Couleur et forme :SolidMasse moléculaire :387.43Acumapimod
CAS :<p>Acumapimod (BCT-197) is an orally active inhibitor of p38α MAPK (IC50 <1 μM).</p>Formule :C22H19N5O2Degré de pureté :≥95%Couleur et forme :SolidMasse moléculaire :385.42KO-947
CAS :<p>KO-947 is a potent and specific inhibitor of ERK1/2 kinases.</p>Formule :C21H17N5ODegré de pureté :97.84%Couleur et forme :SolidMasse moléculaire :355.39BMS-582949 hydrochloride
CAS :<p>The BMS-582949 hydrochloride (BMS-582949 HCl) is a highly specific p38α MAPK inhibitor (IC50: 13 nM).</p>Formule :C22H27ClN6O2Degré de pureté :97.57% - 98.75%Couleur et forme :SolidMasse moléculaire :442.95sodium lauroyl-α-hydroxyethyl sulfonate
CAS :<p>Sodium houttuyfonate is anti-pseudomonas agents, inhibits virulence-related motility of Pseudomonas.</p>Formule :C14H27NaO5SDegré de pureté :≥98% - ≥98%Couleur et forme :SolidMasse moléculaire :330.41DB07268
CAS :<p>DB07268 is a potent and selective JNK1 inhibitor.</p>Formule :C17H15N5O2Degré de pureté :98.2% - 98.91%Couleur et forme :SolidMasse moléculaire :321.33p-Cresyl sulfate potassium
CAS :<p>p-Cresyl sulfate potassium (p-Tolyl sulfate potassium salt) is a prototype protein-bound uremic toxin derived from the metabolites of tyrosine and phenylalanine</p>Formule :C7H7KO4SDegré de pureté :99.38%Couleur et forme :SolidMasse moléculaire :226.29XMD17-109
CAS :<p>XMD17-109 (ERK5-IN-1) is a new selective ERK-5 inhibitor (EC50: 4.2 uM, HEK293 cells).</p>Formule :C36H46N8O3Degré de pureté :98.75% - 99.7%Couleur et forme :SolidMasse moléculaire :638.8Compound 3344 hydrochloride
<p>Compound 3344 hydrochloride is an inhibitor of KRAS-effector interactions，with an affnity of 126nm.</p>Formule :C24H27ClN2O3Degré de pureté :99.23%Couleur et forme :SolidMasse moléculaire :426.94Rasarfin
CAS :<p>Rasarfin inhibits Ras and ARF6.</p>Formule :C23H24ClN3O3Degré de pureté :97.98%Couleur et forme :SolidMasse moléculaire :425.91BMS582949
CAS :<p>BMS-582949 inhibits p38 MAPK with 13 nM IC50, blocking kinase activity and activation.</p>Formule :C22H26N6O2Degré de pureté :98.11%Couleur et forme :SolidMasse moléculaire :406.48CAY10404
CAS :<p>CAY10404: potent COX-1/2 inhibitor; blocks PKB/Akt, MAPK pathways; triggers NSC-LC apoptosis; analgesic, anti-inflammatory, anti-cancer.</p>Formule :C17H12F3NO3SDegré de pureté :99.02%Couleur et forme :SolidMasse moléculaire :367.34K-Ras(G12C) inhibitor 9
CAS :<p>K-Ras(G12C) inhibitor 9 is an allosteric inhibitor of oncogenic K-Ras(G12C).</p>Formule :C16H21ClIN3O4SDegré de pureté :97.33% - 97.45%Couleur et forme :SolidMasse moléculaire :513.78SB-590885
CAS :<p>SB590885 is an effective B-Raf inhibitor (Ki: 0.16 nM, in a cell-free assay).</p>Formule :C27H27N5O2Degré de pureté :95.42% - 99.06%Couleur et forme :SolidMasse moléculaire :453.54ZT-12-037-01
CAS :<p>Zt-12-037-01 is a ATP competitive STK19 inhibitor（IC50 values of 23.96 nM and 27.94 nM for STK19 (WT) and STK19 (D89N),respectively).</p>Formule :C21H31N5O2Degré de pureté :99.56%Couleur et forme :SolidMasse moléculaire :385.5JNK-IN-7
CAS :<p>JNK-IN-7 (JNK inhibitor) is a selective JNK1/2/3 inhibitor (IC50: 1.54/1.99/0.75 nM).</p>Formule :C28H27N7O2Degré de pureté :98.02% - 99.53%Couleur et forme :SolidMasse moléculaire :493.56PF-06260933
CAS :<p>PF-06260933 is a highly selective small-molecule MAP4K4 inhibitor with IC50s of 3.7 and 160 nM for kinase and cell, respectively.</p>Formule :C16H13ClN4Degré de pureté :99.63% - 99.97%Couleur et forme :SolidMasse moléculaire :296.75CK1-IN-1
CAS :<p>CK1-IN-1, a CK1 inhibitor with IC50: 15nM CK1δ, 16nM CK1ε, 73nM p38σ; patent WO2015119579A1.</p>Formule :C24H15F2N3Degré de pureté :98.79%Couleur et forme :SolidMasse moléculaire :383.39N-tert-butyl-α-Phenylnitrone
CAS :<p>N-tert-butyl-α-Phenylnitrone ((Z)-N-benzylidene-2-Methylpropan-2-aMine oxide) inhibits COX2 catalytic activity.</p>Formule :C11H15NODegré de pureté :99.46% - 99.84%Couleur et forme :SolidMasse moléculaire :177.24B-Raf IN 1
CAS :<p>B-Raf IN 1 is a B-Raf (IC50: 24 nM) and c-Raf (IC50: 25 nM) inhibitor.</p>Formule :C29H24F3N5ODegré de pureté :97.22% - 99.27%Couleur et forme :SolidMasse moléculaire :515.53ERK5-IN-1
CAS :<p>ERK5-IN-1 is a potent ERK5 inhibitor (IC50: 87 nM). It also inhibits LRRK2[G2019S] (IC50: 26 nM).</p>Formule :C25H29N7O2Degré de pureté :97.70%Couleur et forme :SolidMasse moléculaire :459.54Ulixertinib
CAS :<p>Ulixertinib (VRT752271) (BVD-523, VRT752271) is an effective and reversible ERK1/ERK2 inhibitor. The IC50 of Ulixertinib is less than 0.3 nM for ERK2.</p>Formule :C21H22Cl2N4O2Degré de pureté :99.31% - 99.95%Couleur et forme :SolidMasse moléculaire :433.33I-49 free base
<p>I-49 free base (Pyrido[4,3-d]pyrimidin-7(6H)-one, 2-methyl-4-[[(1R)-1-[2-methyl-3-(trifluoromethyl)phenyl]ethyl]amino]-6-(tetrahydro-2H-pyran-4-yl)-) is a novel</p>Formule :C23H26ClF3N4O2Degré de pureté :99.64% - 99.88%Couleur et forme :SolidMasse moléculaire :482.92JNK Inhibitor VIII
CAS :<p>JNK Inhibitor VIII (TCS JNK 6o) is an ATP-competitive selective inhibitor of c-Jun N-terminal kinase (JNK)(IC50 values of 45 nM and 160 nM for JNK-1 and -2,</p>Formule :C18H20N4O4Degré de pureté :98.93%Couleur et forme :SolidMasse moléculaire :356.38ARS-1620
CAS :<p>ARS-1620 is a covalent inhibitor of K-RASG12C.</p>Formule :C21H17ClF2N4O2Degré de pureté :98.86%Couleur et forme :SolidMasse moléculaire :430.84Neflamapimod
CAS :<p>Neflamapimod (VX-745) , a specific and effective inhibitor of p38α(IC50=10 nM), is 22-fold greater specificity against p38β and no inhibition activity to p38γ.</p>Formule :C19H9Cl2F2N3OSDegré de pureté :97.88% - 99.75%Couleur et forme :SolidMasse moléculaire :436.26Belvarafenib TFA
<p>Belvarafenib TFA (HM95573 TFA) inhibits RAF: B-RAF (56 nM), B-RAFv600E (7 nM), C-RAF (5 nM) effectively.</p>Formule :C25H17ClF4N6O3SCouleur et forme :SolidMasse moléculaire :592.95K-Ras-IN-1
CAS :<p>K-Ras-IN-1 is a K-Ras inhibitor.</p>Formule :C11H13NOSDegré de pureté :98.72%Couleur et forme :SolidMasse moléculaire :207.29JNK-IN-8
CAS :<p>JNK-IN-8 (JNK Inhibitor XVI) is an irreversible JNK1/2/4 inhibitor (IC50: 4.7/18.7/1 nM).</p>Formule :C29H29N7O2Degré de pureté :99.24% - >99.99%Couleur et forme :SolidMasse moléculaire :507.59SUN11602
CAS :<p>SUN11602, an aniline compound, mimics the neuroprotective mechanisms of basic fibroblast growth factor.</p>Formule :C26H37N5O2Degré de pureté :99.36%Couleur et forme :SolidMasse moléculaire :451.6KRPEP-2D acetate
<p>KRPEP-2D acetate: inhibitor targeting K-Ras(G12D) mutant, a crucial cancer-related protein.</p>Formule :C110H186N44O27S2Degré de pureté :98.94%Couleur et forme :SolidMasse moléculaire :2621.06VX-11e
CAS :<p>VX-11e (TCS ERK 11e) is a potent, selective, and orally bioavailable ERK(Extracellular Signal-Regulated Kinase) inhibitor; antitumor agent.</p>Formule :C24H20Cl2FN5O2Degré de pureté :98.92% - ≥98%Couleur et forme :SolidMasse moléculaire :500.35Plx-4032
CAS :<p>Plx-4032 (Vemurafenib) is a small-molecule B-Raf inhibitor for the potential treatment of malignant melanoma.</p>Formule :C23H18ClF2N3O3SDegré de pureté :98.53% - 99.36%Couleur et forme :SolidMasse moléculaire :489.92Refametinib
CAS :<p>Refametinib (RDEA119) (RDEA119, Bay 86-9766) is an effective, ATP non-competitive and specific inhibitor of MEK1/2 (IC50: 19/47 nM).</p>Formule :C19H20F3IN2O5SDegré de pureté :99.53% - >99.99%Couleur et forme :SolidMasse moléculaire :572.34TA-02
CAS :<p>TA-02 is a p38 MAPK inhibitor with IC50 of 20 nM.TA-02 especially inhibits TGFBR-2.</p>Formule :C20H13F2N3Degré de pureté :99.35% - 99.79%Couleur et forme :SolidMasse moléculaire :333.33SD-169
CAS :<p>SD-169 (SD 169) is a selective and ATP competitive the MAP kinases p38α and p38β inhibitor.</p>Formule :C9H8N2ODegré de pureté :98.6%Couleur et forme :SolidMasse moléculaire :160.17SM-7368
CAS :<p>The NF-κB Activation Inhibitor III, controls the biological activity of NF-κB. It is primarily used for Inflammation/Immunology applications.</p>Formule :C10H5ClN4O5SDegré de pureté :99.64%Couleur et forme :SolidMasse moléculaire :328.696H05 (TFA)
CAS :<p>6H05 TFA (6H05 trifluoroacetate) is a selective, and allosteric oncogenic mutant K-Ras(G12C) inhibitor.</p>Formule :C22H31ClF3N3O4S3Degré de pureté :98.83%Couleur et forme :SolidMasse moléculaire :590.14ML-098
CAS :<p>ML-098 (CID-7345532) is an activator of the GTP-binding protein Rab7 (EC50: 77.6 nM).</p>Formule :C19H19NO3Degré de pureté :99.06% - 99.23%Couleur et forme :SolidMasse moléculaire :309.36MK2-IN-3
CAS :<p>MK2-IN-3 is a potent MK-2 inhibitor, cell-permeable, for rheumatoid arthritis treatment.</p>Formule :C21H16N4ODegré de pureté :99.01%Couleur et forme :SolidMasse moléculaire :340.381-(4-methansulfinylphenyl)ethanone
CAS :<p>The compound inhibits Ras function and therefore inhibits the abnormal growth of cells.</p>Formule :C9H10O2SDegré de pureté :99.48%Couleur et forme :SolidMasse moléculaire :182.24CCT196969
CAS :<p>CCT196969 is a novel orally available, pan-RAF inhibitor with anti-SRC activity. It also inhibits SRC, LCK, and the p38 MAPKs.</p>Formule :C27H24FN7O3Degré de pureté :98.93% - 99.65%Couleur et forme :SolidMasse moléculaire :513.52Cefotetan
CAS :<p>Cefotetan, a cephamycin antibiotic, fights various bacteria by disrupting cell wall synthesis.</p>Formule :C17H17N7O8S4Degré de pureté :95.72% - 99.38%Couleur et forme :SolidMasse moléculaire :575.62SD 0006
CAS :<p>SD 0006 (SD-06) is a MAPK p38 alpha inhibitor( IC50 : 110 nM) for the treatment of arthritis.</p>Formule :C20H20ClN5O2Degré de pureté :98.32%Couleur et forme :SolidMasse moléculaire :397.86CMPD1
CAS :<p>CMPD1 is a non-ATP-competitive p38 MAPK-mediated MK2 phosphorylation inhibitor(apparent Ki (Kiapp): 330 nM).</p>Formule :C22H20FNO2Degré de pureté :99.8%Couleur et forme :SolidMasse moléculaire :349.4Talmapimod
CAS :<p>Talmapimod (SCIO-469): Oral ATP-competitive p38α inhibitor, IC50 = 9 nM (p38α), 90 nM (p38β), >2000-fold selectivity over 20 kinases.</p>Formule :C27H30ClFN4O3Degré de pureté :98% - 99.9%Couleur et forme :SolidMasse moléculaire :513AZ7550
CAS :<p>AZ7550, an active metabolite of AZD9291, inhibits the activity of IGF1R (IC50: 1.6 μM).</p>Formule :C27H31N7O2Degré de pureté :97.07% - 99.75%Couleur et forme :SolidMasse moléculaire :485.581588-A4
CAS :<p>1588-A4 (ARS-1620 Intermediate) is an intermediate of ARS-1620 which is an atropisomeric selective KRASG12C inhibitor with desirable pharmacokinetics.</p>Formule :C17H19BrClFN4O2Degré de pureté :98.59%Couleur et forme :SolidMasse moléculaire :445.71GSK-114
CAS :<p>GSK-114, a TNNI3K inhibitor with a 25 nM IC50, is 40x more selective than B-Raf and good for in vivo studies.</p>Formule :C19H23N5O4SDegré de pureté :99.51%Couleur et forme :SolidMasse moléculaire :417.48Varenicline Tartrate
CAS :<p>Varenicline Tartrate (CP 526555-18) is a benzazepine derivative that functions as an ALPHA4/BETA2 NICOTINIC RECEPTOR partial agonist.</p>Formule :C13H13N3·C4H6O6Degré de pureté :98.23% - 98.32%Couleur et forme :Tan SolidMasse moléculaire :361.35Encorafenib
CAS :<p>Encorafenib (LGX818) is an orally available mutated BRaf V600E inhibitor(IC50=0.3 nM) with potential antineoplastic activity.</p>Formule :C22H27ClFN7O4SDegré de pureté :99.51% - 99.83%Couleur et forme :SolidMasse moléculaire :540.01AG126
CAS :<p>AG126 (Tyrphostin AG126) selectively inhibits the phosphorylation of ERK1 (p44) and ERK2 (p42). AG-126 weakly inhibits epidermal GFRK and platelet-derived GFRK.</p>Formule :C10H5N3O3Degré de pureté :97.35%Couleur et forme :SolidMasse moléculaire :215.16D-JNKI-1 acetate
<p>D-JNKI-1 acetate (AM-111 acetate) is a highly potent and cell-permeable peptide inhibitor of JNK.</p>Formule :C166H290N66O42Degré de pureté :99.48%Couleur et forme :SolidMasse moléculaire :3882.5
